enGene amends CEO Ron Cooper's severance to 1.5x target bonus on change-in-control termination

enGene Therapeutics Inc.

Board approved amendment to Cooper Employment Agreement, effective October 2, 2025.
CIC termination severance multiplier increased from 1.0x to 1.5x annual target bonus.
Lump sum payment payable within 45 days of CIC termination, subject to compliance.
Amendment recommended by Compensation Committee; full text to be filed in 10-K for FY ending Oct 31, 2025.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.